跳至主要内容
临床试验/NCT04050956
NCT04050956招募中不适用

French Cohort of Myocardial Infarction Evaluation

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 30,000 人开始时间: 2019年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30,000
试验地点
1
主要终点
In-hospital outcomes

研究概览

简要总结

Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively.

The aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.

详细描述

The FRENCHIE registry is a French multicenter prospective observational study. All the eligible consecutive patients admitted within 48 hours after symptom onset in a cardiac ICU for an acute myocardial infarction.

This hospital registry will be linked to the national databases, in order to collect follow-up clinical outcomes and health care consumption.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical increased or fall of troponin (or CPKMB) associated with at least one of the following elements :
  • Symptoms compatible with myocardial ischemia
  • Appearance of pathological Q waves
  • ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)
  • Written consent.
  • Covered by French medical insurance ("Sécurité Sociale")

排除标准

  • Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
  • AMI diagnosis invalidated in favor of another diagnosis

结局指标

主要结局

In-hospital outcomes

时间窗: Through the end of initial hospitalization, an average of 5 days

To measure the in-hospital major cardiovascular events : recurrence of AMI, myocardial revascularization, stroke

Lipopretein 1 evolution

时间窗: 9 months after the end of initial hospitalization

To evaluate plasma concentrations of Lpa and its dynamic pattern during hospital index and 3-9 months following hospitalization.

In-hospital mortality

时间窗: Through the end of initial hospitalization, an average of 5 days

In-hospital mortality

次要结局

  • Non cardiovascular outcomes during follow-up(Up to 20 years)
  • Relationship between patients profile and mortality and cardiovascular morbidity outcomes according to management(Up to 20 years)
  • Oral comorbidities(Up to 20 years)
  • Evaluate the path of care combined with patient care practices following an acute myocardial infarction(Up to 20 years)
  • Cardiovascular outcomes during follow-up(Up to 20 years)
  • Relationship between patients profile and mortality and non-cardiovascular morbidity outcomes according to management(Up to 20 years)
  • Sleep disordered breathing comorbidities(Up to 20 years)
  • Evaluate the relevance of European Society of Cardiology (ESC), American Heart Association/American College of Cardiology (AHA / ACC) guidelines regarding management of AMI patients(Up to 20 years)
  • Cost-utility: incremental (or decremental) cost-utility ratio during follow-up(Up to 20 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验